DK0983342T3 - Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse - Google Patents

Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse

Info

Publication number
DK0983342T3
DK0983342T3 DK98923023T DK98923023T DK0983342T3 DK 0983342 T3 DK0983342 T3 DK 0983342T3 DK 98923023 T DK98923023 T DK 98923023T DK 98923023 T DK98923023 T DK 98923023T DK 0983342 T3 DK0983342 T3 DK 0983342T3
Authority
DK
Denmark
Prior art keywords
animal
amino acid
culture medium
complexes
acid source
Prior art date
Application number
DK98923023T
Other languages
Danish (da)
English (en)
Inventor
Roberto Olivieri
Maria Kontakou
Lucia Tagliaferri
Antonella Giglioli
Fabio Sabbatini
Rino Rappuoli
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9710981.3A external-priority patent/GB9710981D0/en
Priority claimed from GBGB9806802.6A external-priority patent/GB9806802D0/en
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of DK0983342T3 publication Critical patent/DK0983342T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/21—Haemophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98923023T 1997-05-28 1998-05-28 Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse DK0983342T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9710981.3A GB9710981D0 (en) 1997-05-28 1997-05-28 Culture medium
GBGB9806802.6A GB9806802D0 (en) 1998-03-30 1998-03-30 Culture medium
PCT/IB1998/000938 WO1998054296A1 (en) 1997-05-28 1998-05-28 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin

Publications (1)

Publication Number Publication Date
DK0983342T3 true DK0983342T3 (da) 2008-01-07

Family

ID=26311607

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98923023T DK0983342T3 (da) 1997-05-28 1998-05-28 Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse

Country Status (10)

Country Link
EP (4) EP1849860B1 (ja)
JP (3) JP4173560B2 (ja)
AT (2) ATE488574T1 (ja)
AU (1) AU7545298A (ja)
CY (2) CY1107812T1 (ja)
DE (2) DE69842010D1 (ja)
DK (1) DK0983342T3 (ja)
ES (1) ES2293681T3 (ja)
PT (2) PT1849860E (ja)
WO (1) WO1998054296A1 (ja)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US6558926B1 (en) * 1999-07-16 2003-05-06 Massachusetts Institute Of Technology Method for production of tetanus toxin using media substantially free of animal products
EP1074612A1 (en) * 1999-08-04 2001-02-07 Pasteur Merieux Serums Et Vaccins Use of vegetal peptones for DNA vaccine production
EA006947B1 (ru) 2001-01-23 2006-06-30 Авентис Пастер Поливалентная менингококковая полисахаридно-белковая конъюгированная вакцина
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
AU2003299501A1 (en) * 2002-05-16 2004-05-04 Aventis Pasteur, Inc. Animal component free meningococcal polysaccharide fermentation and seedbank development
JP2005532057A (ja) 2002-07-09 2005-10-27 バクスター・インターナショナル・インコーポレイテッド 細胞を培養するための動物性タンパク質非含有培地
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US7148041B2 (en) 2003-09-25 2006-12-12 Allergan, Inc. Animal product free media and processes for obtaining a botulinum toxin
US7160699B2 (en) 2003-09-25 2007-01-09 Allergan, Inc. Media for clostridium bacterium and processes for obtaining a clostridial toxin
US7452697B2 (en) 2003-09-25 2008-11-18 Allergan, Inc. Chromatographic method and system for purifying a botulinum toxin
US7354740B2 (en) 2003-09-25 2008-04-08 Allergan, Inc. Animal product free system and process for purifying a botulinum toxin
WO2005054443A1 (en) * 2003-12-03 2005-06-16 Aventis Pasteur Limited Cryo-protective agents for microorganisms
US20110097359A1 (en) * 2003-12-12 2011-04-28 Tim Lee Production of diphtheria toxin
GB0408978D0 (en) * 2004-04-22 2004-05-26 Chiron Srl Meningococcal fermentation for preparing conjugate vaccines
WO2006042542A2 (en) * 2004-10-19 2006-04-27 Statens Serum Institut Production of tetanus, diphtheria, and pertussis toxins and toxoids using fermentation media containing no components of animal or soy origin
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
NL1029059C2 (nl) * 2005-05-17 2006-11-20 Noord Nl Oliemolen Holding B V Peptidenpreparaat voor het groeien en/of kweken van micro-organismen en/of cellen.
SI1869161T1 (sl) * 2005-10-11 2010-05-31 Probiotical Spa Postopek za pripravo nealergijskih probiotičnih bakterijskih kultur in ustrezna uporaba
EP2522717B1 (en) 2006-01-04 2014-04-02 Baxter International Inc Oligopeptide-free cell culture media
EP1893033B1 (en) * 2006-07-07 2008-10-22 Alpro NV Method for preparing a dairy analogue
DK2114421T3 (en) 2007-03-05 2018-04-23 Om Pharma BACTERIA EXTRACTS FOR RESPIRATORY DISORDERS AND PROCEDURES FOR PREPARING THEREOF
FR2918671B1 (fr) 2007-07-10 2010-10-15 Sanofi Pasteur Milieu de culture d'haemophilus influenzae type b.
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
EP2275527A1 (en) * 2009-07-17 2011-01-19 ActoGeniX NV Animal component-free culture medium for bacterial fermentation
GB2495341B (en) 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
DE102011122891B4 (de) 2011-11-11 2014-12-24 Novartis Ag Fermentationsmedium, das frei von tierischen Bestandteilen ist, zur Herstellung von Diphtherie-Toxoiden zur Verwendung bei der Impfung von Menschen
DE102011118371B4 (de) 2011-11-11 2014-02-13 Novartis Ag Zur Impfung von Menschen geeignete Zusammensetzung, die ein Diphtherie-Toxoid umfasst, sowie Verfahren zu deren Herstellung
EP2592137A1 (en) 2011-11-11 2013-05-15 Novartis AG Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
BR102012013110A2 (pt) 2012-05-31 2014-05-27 Cristalia Prod Quimicos Farm Meio de cultura para bactérias do gênero clostridium livre de componentes de origem animal e processo para produção de sobrenadante contendo uma ou mais proteases com atividade colagenolítica e gelatinolítica
CN104263678A (zh) * 2014-09-02 2015-01-07 成都欧林生物科技股份有限公司 一种白喉杆菌培养基及应用其制备白喉类毒素的方法
EP3783010A1 (en) 2015-05-06 2021-02-24 Wageningen Universiteit Method of culturing akkermansia
CA3138763A1 (en) 2015-11-17 2017-05-26 Pfizer, Inc. Media and fermentation methods for producing polysaccharides in bacterial cell culture
HUE059629T2 (hu) 2017-04-22 2022-12-28 Biological E Ltd Javított eljárás CRM nagy mennyiségben történõ elõállítására
BR112021013241A2 (pt) * 2019-01-04 2021-09-14 Boehringer Ingelheim Animal Health USA Inc. Cepas atenuadas de bordetella bronchiseptica, vacinas orais contendo as cepas atenuadas e métodos de preparação e uso das mesmas
CN112646747B (zh) * 2021-01-08 2024-03-15 苏州聚微生物科技有限公司 破伤风梭状芽孢杆菌培养基

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
GB8924438D0 (en) * 1989-10-31 1989-12-20 Hoffmann La Roche Vaccine composition
DD294502A5 (de) 1990-05-15 1991-10-02 Dessau Tornau Impfstoffwerk Verfahren zur herstellung eines sojahydrolysats fuer mikrobiologische zwecke
IT1251751B (it) * 1991-10-31 1995-05-23 Sclavo Ricerca S R L Metodo per la coltura di microrganismi dei generi helicobacter, campylobacter e arcobacter, utilizzando terreni di coltura contenenti ciclodestrine o metil-cellulosa o loro miscele
DE4220889A1 (de) * 1992-06-25 1994-02-24 Mueller Karl & Co Kg Reaktivierungsmischung für Starterkulturen zur Rohwurstherstellung
US5314822A (en) * 1992-10-15 1994-05-24 Merck & Co., Inc. Method of clonal growth of Streptococcus pneumoniae
EP0624376B1 (en) * 1993-05-13 2000-03-15 American Cyanamid Company Preparation and uses of LOS-depleted outer membrane proteins of gram-negative cocci
US5494808A (en) * 1994-09-15 1996-02-27 Merck & Co., Inc. Defined medium OMPC fermentation process
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
GB9422331D0 (en) * 1994-11-04 1994-12-21 Biocine Spa H. pylori fermentation process

Also Published As

Publication number Publication date
DE69838383T2 (de) 2008-06-05
ES2293681T3 (es) 2008-03-16
JP4173560B2 (ja) 2008-10-29
JP2002501387A (ja) 2002-01-15
EP2267113A1 (en) 2010-12-29
JP2012005495A (ja) 2012-01-12
EP0983342B1 (en) 2007-09-05
EP1849860A2 (en) 2007-10-31
PT1849860E (pt) 2011-02-23
EP2199382A2 (en) 2010-06-23
EP1849860A3 (en) 2008-04-02
EP0983342A1 (en) 2000-03-08
WO1998054296A1 (en) 1998-12-03
ATE488574T1 (de) 2010-12-15
CY1107812T1 (el) 2013-06-19
ATE372376T1 (de) 2007-09-15
JP2008200047A (ja) 2008-09-04
CY1111178T1 (el) 2015-06-11
EP2267113B1 (en) 2013-07-17
EP1849860B1 (en) 2010-11-17
DE69838383D1 (de) 2007-10-18
AU7545298A (en) 1998-12-30
PT983342E (pt) 2007-12-13
EP2199382A3 (en) 2010-09-22
DE69842010D1 (de) 2010-12-30

Similar Documents

Publication Publication Date Title
DK0983342T3 (da) Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse
HK1108713A1 (en) Animal protein free media for cultivation of cells
DE69332981D1 (de) Methoden zur herstellung löslicher, oligomerer proteine
DE69840448D1 (de) 13c,15n,2h markierte proteine zur nmr strukturbestimmung und deren herstellung
ATA165999A (de) Medium zur protein- und serumfreien kultivierung von zellen
ATE490336T1 (de) Verfahren zur verbesserten isolierung rekombinant produzierter proteine
BR9906927A (pt) Proteìnas de neisseria meningitidis
WO2001005997A3 (en) Method for production of tetanus toxin using media substantially free of animal products
ATE542891T1 (de) Verfahren zur herstellung von biologischen produkten in protein-freier kultur
BRPI0418317A (pt) vacina de aumento de crescimento à base de epitopo de neutralização
DK1085083T3 (da) Dyrkningsmedium for dyreceller og fremgangsmåde til proteinfremstilling under anvendelse af dette
DE59101580D1 (de) Trägergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine.
DK0395532T3 (da) Isoleringsmedium til identifikation af Salmonella-bakterier
HUP0101081A2 (hu) Tápközeg és eljárás vírustenyésztésre és szaporításra
FI102544B1 (fi) Menetelmä E.coli-kannan valmistamiseksi
ES2164125T3 (es) Procedimiento para la preparacion de l-leucina.
ATE552334T1 (de) Serumfreies medium zur herstellung von retroviralen vektoren
DK364081A (da) D-n-carbamoyl-alfa-aminosyrer og fremgangsmaade til fremstilling heraf
DK1242602T3 (da) Proteinekspressionssystemer for ikke-patogene kinetoplastidae
DK0759981T3 (da) Fremgangsmåde til dyrkning af bakterier, der producerer proteiner, som udtrykkes på en temperaturreguleret måde
ATE305515T1 (de) Nukleotidsequenzen kodierend fur proteine beteiligt an der biosynthese von l-serin, verbessertes verfahren zur mikrobiellen herstellung von l-serin sowie ein dazu geeigneter genetisch veranderter mikroorganismus
SE9403636D0 (sv) Vaccine preparation
NO994788L (no) Fremgangsmåte for fremstilling av heterolog protein
NL300073I1 (nl) Vaccin.
WO2001044278A3 (en) Antigen preparations